Peroxisomal Biogenesis Factor 13 (PEX13) (C-Term) Peptide
Quick Overview for Peroxisomal Biogenesis Factor 13 (PEX13) (C-Term) Peptide (ABIN8107872)
Target
Origin
Source
Application
-
-
Protein Region
- C-Term
-
Purpose
- PEX13 Peptide - C-terminal region
-
Sequence
- SFTNPTLTKG ATVADSLDEQ EAAFESVFVE TNKVPVAPDS IGKDGEKQDL
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-PEX13 Antibody (ARP64105_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- PEX13 (Peroxisomal Biogenesis Factor 13 (PEX13))
-
Background
-
Background Information: This gene encodes a peroxisomal membrane protein that binds the type 1 peroxisomal targeting signal receptor via a SH3 domain located in the cytoplasm. Mutations and deficiencies in peroxisomal protein importing and peroxisome assembly lead to peroxisomal biogenesis disorders, an example of which is Zellweger syndrome.
Alternative Symbols: NALD, ZWS
-
Molecular Weight
- 44kDa
-
Gene ID
- 5194
-
NCBI Accession
- NP_002609
-
UniProt
- Q92968
Target
-